Cellebrite Enhances Investigative Analytics Solution with Amazon Web Services (AWS)

Go back to Cellebrite Enhances Investigative Analytics Solution with Amazon Web Services (AWS)

BofA Securities Reiterates Buy Rating on Amazon.com (AMZN), PT $210, 'we think AWS remains well-positioned'

September 17, 2024 9:32 AM EDT

BofA Securities analyst Justin Post reiterated a Buy rating and $210.00 price target on Amazon.com (NASDAQ: AMZN).

The analyst comments "Bloomberg reported that AWS and Intel will coinvest in custom chip designs under a "multi-year, multi-billion-dollar" partnership. As part of the... More